SCHEMBL15536406

SCHEMBL15536406

CC(C)(C)OC(=O)c1cc(C2CC2)c(OCC2CN(C(c3ccccc3)c3ccccc3)C2)cc1F

nearest known ligand 0.70

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ SCN9A Q15858 16/20 0.70
▸ SCN7A Q01118 6/20 0.70
▸ SCN5A Q14524 5/20 0.70
▸ SCN2B O60939 1/20 0.43
▸ SCN1A P35498 1/20 0.43
▸ SCN4A P35499 1/20 0.43
▸ SCN1B Q07699 1/20 0.43
▸ SCN2A Q99250 1/20 0.43
▸ SCN8A Q9UQD0 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16759224 0.93 SCN9A (0.61) SCN9ASCN7ASCN5ASCN2BSCN1A
SCHEMBL17062754 0.93 SCN9A (0.61) SCN9ASCN7ASCN5ASCN2BSCN1A
SCHEMBL16759392 0.93 SCN9A (0.61) SCN9ASCN7ASCN5ASCN2BSCN1A
SCHEMBL16759164 0.93 SCN9A (0.61) SCN9ASCN7ASCN5ASCN2BSCN1A
SCHEMBL21825393 0.91 SCN9A (0.56) SCN9ASCN7ASCN5A
SCHEMBL15536661 0.88 SCN9A (0.54) SCN9ASCN7ASCN5A
SCHEMBL15536684 0.88 SCN9A (0.75) SCN9ASCN7ASCN5A
SCHEMBL16448749 0.86 SCN9A (0.68) SCN9ASCN7ASCN5A
SCHEMBL23159379 0.85 SCN9A (0.82) SCN9ASCN7ASCN5ASCN2BSCN1A
SCHEMBL15536170 0.85 SCN9A (0.69) SCN9ASCN7ASCN5ASCN2BSCN1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105793238-B Substituted benzamides and methods of use thereof 基因泰克公司 2019-12-24 — — CN disclosed
EP-2855428-A1 N-SUBSTITUTED BENZAMIDES AND THEIR USE IN THE TREATMENT OF PAIN Genentech, Inc. (US) 2015-04-08 — — EP disclosed
WO-2013177224-A1 N-SUBSTITUTED BENZAMIDES AND THEIR USE IN THE TREATMENT OF PAIN GENENTECH, INC. (US) 2013-11-28 — — WO disclosed
Send feedback